DJIA 17,077.25 -21.20 -0.12%
NASDAQ 4,589.87 9.60 0.21%
S&P 500 1,999.82 -3.55 -0.18%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)

92.95 -0.62 (-0.66%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRTX $92.95 -0.66%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $94.29
Previous Close $93.57
Daily Range $92.53 - $94.30
52-Week Range $58.06 - $99.74
Market Cap $22.1B
P/E Ratio -47.02
Dividend (Yield) $0.00 (0.0%)
Volume 356,602
Average Daily Volume 1,315,926
Current FY EPS -$2.81

Sector

Healthcare

Industry

Drugs

Vertex Pharmaceuticals (VRTX) Description

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Website: http://www.vrtx.com/

News & Commentary

Has Gilead Sciences, Inc.'s Star Drug Already Peaked?

Prescriptions of Gilead Sciences' hepatitis C drug Sovaldi peaked, but sales will pick up after the new combination product is approved.

Nasdaq 100 Movers: VIP, VRTX

Guggenheim S&P 500 Equal Weight ETF Experiences Big Inflow

3 Drugs Stocks Dragging The Industry Down

Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains in Focus - Anal

Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains in Focus - Analyst Blog

Stock Market Today: Equities Rally Despite Poor Retail Earnings - Stocks in the News

Wednesday's ETF with Unusual Volume: PBP

S&P 500 Movers: VRTX, KMI

Nasdaq 100 Movers: ILMN, TSLA

10 stocks suffering the biggest cuts in earnings estimates

See More VRTX News...

VRTX's Top Competitors

VRTX $92.95 (-0.66%)
Current stock: VRTX
AMGN $137.78 (-1.15%)
Current stock: AMGN
GILD $109.13 (1.46%)
Current stock: GILD
BIIB $341.34 (-0.50%)
Current stock: BIIB